Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Kalvista Pharmaceuticals (KALV) Q3 2023 Earnings
KALV
7
Dec
Confirmed
Q4 2022
Q2 2023
Q2 2023
Q3 2023
-0.98
-0.9
-0.82
-0.74
Details
Expected EPS
-0.79
Actual EPS
-0.8
Surprise EPS
-0.01
Surprise Percent
+1.27%
Description
Kalvista Pharmaceuticals (KALV) has reported earnings of -0.8 per share for Q3 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login